Clinical Trials Directory

Trials / Completed

CompletedNCT02079311

Evaluation of Core Body Temperature When Using Forced Air Warming or an Active Blanket to Prevent Perioperative Hypothermia

Evaluation of Perioperative Core Body Temperature When Using Forced Air Warming or BARRIER® EasyWarm to Prevent Inadvertent Perioperative Hypothermia: An Open-label, Randomized Non-inferiority Comparison

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Molnlycke Health Care AB · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This investigation is undertaken to investigate if patient warming with BARRIER® EasyWarm active self-warming blanket differs compared to active warming with forced air warming in terms of core body temperature perioperatively. A non-inferiority, prospective, open-labelled, randomized, parallel investigation. Randomized subjects will receive active warming with BARRIER® EasyWarm or with forced air warming. All subjects may receive rescue warming if their core temperature falls below 35.5°C. Rescue warming is optional and defined as the institution's standard of care to prevent hypothermia. The primary purpose is to investigate if there is a clinically relevant difference in core body temperature between the two treatment groups. A total of 60 subjects will be included in the investigation, i.e. 30 subjects in each treatment group. The number includes a 30% drop-out rate.

Conditions

Interventions

TypeNameDescription
DEVICEActive self warming blanketBARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.
DEVICEForced air warming deviceForced air warming is a temperature management unit, where heated air is used to warm subjects through convection.

Timeline

Start date
2014-01-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2014-03-05
Last updated
2015-11-13
Results posted
2015-11-13

Locations

3 sites across 3 countries: Germany, Norway, United Kingdom

Source: ClinicalTrials.gov record NCT02079311. Inclusion in this directory is not an endorsement.